BioTel Research Blog

blogBlog

Progress in Immune-Oncology Imaging

The advent of immune checkpoint inhibition and other immune-related therapies has produced a sea change in the treatment of a wide range of oncology indications. The impact of these new treatment [...]

April 22, 2019

blogBlog

Global NASH Congress 2019

As an attendee at the recent Global Nonalcoholic Steatohepatitis (NASH) Congress in London, England, I was among a good mix of academics and industry. Much of the conference focused on noninvasive [...]

March 15, 2019

blogBlog

February is American Heart Month

February 2019 marks the 55th anniversary of American Heart Month. Originally established by President Lyndon B. Johnson in December 1963, it marked a turning point in our collective approach to [...]

February 15, 2019

blogBlog

Response Assessment in Immune-Oncology

Seven years after the approval of the first immune checkpoint inhibitor for the treatment of metastatic melanoma, immunotherapy remains one of the primary areas of focus for oncology drug [...]

March 13, 2018

blogBlog

NASH-TAG 2018

Ironically, the 2018 NASH-TAG conference in the Rocky Mountains featured much less snow than we have “enjoyed” in the northeast this winter. Weather forced one speaker to present remotely from his [...]

February 15, 2018

blogBlog

Archived Webinar: Body Composition in Clinical Trials – From BMI to MRI

According to the WHO, obesity is an epidemic that kills at least 2.8 million people each year.  The number of obese children and adolescents worldwide has risen tenfold in the past four decades. [...]

January 16, 2018

BioTel Research, One Preserve Parkway, Suite #600, Rockville, MD 20852